Kornberg, M. D., Smith, M. D., Shirazi, H. A., Calabresi, P. A., Snyder, S. H., & Kim, P. M. (2018). Bryostatin-1 alleviates experimental multiple sclerosis. Proceedings of the National Academy of Sciences, 201719902. https://doi.org/10.1073/pnas.1719902115

Calabresi, P. A. (2018). Advances in multiple sclerosis: from reduced relapses to remedies. The Lancet Neurology, 17(1), 10–12. http://doi.org/10.1016/S1474-4422(17)30417-9

Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018). Multiple Sclerosis. New England Journal of Medicine, 378(2), 169–180. http://doi.org/10.1056/NEJMra1401483

Smith, M. D., Calabresi, P. A., & Bhargava, P. (2017). Dimethyl fumarate treatment alters NK cell function in multiple sclerosis. European Journal of Immunology. http://doi.org/10.1002/eji.201747277

Baxi, E. G., DeBruin, J., Jin, J., Strasburger, H. J., Smith, M. D., Orthmann-Murphy, J. L., … Calabresi, P. A. (2017). Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination. Glia. http://doi.org/10.1002/glia.23229

Smith, M. D., Martin, K. A., Calabresi, P. A., & Bhargava, P. (2017). Dimethyl fumarate alters B-cell memory and cytokine production in MS patients. Annals of Clinical and Translational Neurology, 4(5), 351–355. http://doi.org/10.1002/acn3.411

Glenn, J. D., Smith, M. D., Xue, P., Chan-Li, Y., Collins, S., Calabresi, P. A., … Whartenby, K. A. (2017). CNS-targeted autoimmunity leads to increased influenza mortality in mice. The Journal of Experimental Medicine, 214(2), jem.20160517. http://doi.org/10.1084/jem.20160517

Orthmann-Murphy, J. L., & Calabresi, P. A. (2017). Therapeutic Application of Monoclonal Antibodies in Multiple Sclerosis. Clinical Pharmacology and Therapeutics, 101(1), 52–64. http://doi.org/10.1002/cpt.547

Schott, J. T., Kirby, L. A., Calabresi, P. A., & Baxi, E. G. (2016). Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning. Journal of Visualized Experiments, (108), 53764. http://doi.org/10.3791/53764

Bhargava, P., & Calabresi, P. A. (2016). Metabolomics in multiple sclerosis. Multiple Sclerosis Journal, 22(4), 451–460. http://doi.org/10.1177/1352458515622827

Sotirchos, E. S., Bhargava, P., Eckstein, C., Van Haren, K., Baynes, M., Ntranos, A., … Calabresi, P. A. (2016). Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis. Neurology, 86(4), 382–390. http://doi.org/10.1212/WNL.000000000000231

Grishkan, I. V, Tosi, D. M., Bowman, M. D., Harary, M., Calabresi, P. A., & Gocke, A. R. (2015). Antigenic Stimulation of Kv1.3-Deficient Th Cells Gives Rise to a Population of Foxp3-Independent T Cells with Suppressive Properties. Journal of Immunology (Baltimore, Md. : 1950). http://doi.org/10.4049/jimmunol.1403024

Baxi, E. G., DeBruin, J., Tosi, D. M., Grishkan, I. V., Smith, M. D., Kirby, L. A., … Gocke, A. R. (2015). Transfer of Myelin-Reactive Th17 Cells Impairs Endogenous Remyelination in the Central Nervous System of Cuprizone-Fed Mice. Journal of Neuroscience, 35(22), 8626–8639. http://doi.org/10.1523/JNEUROSCI.3817-14.2015

Bhargava, P., Gocke, A., & Calabresi, P. A. (2015). 1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controls. Journal of Neuroimmunology, 279, 20–4. http://doi.org/10.1016/j.jneuroim.2014.12.018

Baxi, E. G., Schott, J. T., Fairchild, A. N., Kirby, L. A., Karani, R., Uapinyoying, P., … Calabresi, P. A. (2014). A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation. Glia, 62(9), 1513–29. http://doi.org/10.1002/glia.22697

Ntranos, A., Hall, O., Robinson, D. P., Grishkan, I. V, Schott, J. T., Tosi, D. M., … Gocke, A. R. (2014). FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway. Journal of Neuroimmunology, 270(1–2), 13–21. http://doi.org/10.1016/j.jneuroim.2014.03.007

Grishkan, I. V, Fairchild, A. N., Calabresi, P. A., & Gocke, A. R. (2013). 1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization. Proceedings of the National Academy of Sciences of the United States of America, 110(52), 21101–6. http://doi.org/10.1073/pnas.1306072110

Grishkan, I. V, Ntranos, A., Calabresi, P. A., & Gocke, A. R. Helper T cells down-regulate CD4 expression upon chronic stimulation giving rise to double-negative T cells. Cellular Immunology, 284(1–2), 68–74. http://doi.org/10.1016/j.cellimm.2013.06.011

Hu, L., Wang, T., Gocke, A. R., Nath, A., Zhang, H., Margolick, J. B., … Calabresi, P. A. (2013). Blockade of Kv1.3 potassium channels inhibits differentiation and granzyme B secretion of human CD8+ T effector memory lymphocytes. PloS One, 8(1), e54267. http://doi.org/10.1371/journal.pone.0054267

Gocke, A. R., Lebson, L. A., Grishkan, I. V, Hu, L., Nguyen, H. M., Whartenby, K. A., … Calabresi, P. A. (2012). Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950), 188(12), 5877–86. http://doi.org/10.4049/jimmunol.1103095

Hu, L., Gocke, A. R., Knapp, E., Rosenzweig, J. M., Grishkan, I. V, Baxi, E. G., … Calabresi, P. A. (2012). Functional blockade of the voltage-gated potassium channel Kv1.3 mediates reversion of T effector to central memory lymphocytes through SMAD3/p21cip1 signaling. The Journal of Biological Chemistry, 287(2), 1261–8. http://doi.org/10.1074/jbc.M111.296798